Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Fasenra
Descriptions
Benralizumab injection is used together with other medicines to treat severe asthma. It is given to patients whose asthma is not controlled with their current asthma medicines. It is also used in patients whose asthma has an eosinophilic phenotype.
Benralizumab helps prevent severe asthma attacks (exacerbations) and may improve your breathing. It also helps reduce blood eosinophils, which are a type of white blood cell that may contribute to your asthma.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2022
Copyright © 2022 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.